临床研究

八段锦联合生物反馈对功能性排便障碍的疗效及脑肠肽的影响

  • 高远 ,
  • 王菁 ,
  • 陈慧 ,
  • 吴加勇 ,
  • 施婧媱 ,
  • 黄铭涵
展开
  • 1.福建中医药大学研究生院,福建福州市 350122;
    2.福建中医药大学附属人民医院,福建福州市 350004;
    3.福建中医药大学附属第二人民医院,福建福州市 350003;
    4.福建中医药大学附属康复医院,福建福州市 350003
高远(1993-),男,汉族,福建福州市人,硕士研究生,主要研究方向:慢性便秘的康复治疗。通讯作者:黄铭涵,男,副主任医师。

收稿日期: 2018-06-22

  修回日期: 2018-07-10

  网络出版日期: 2018-09-27

基金资助

1.福建省科技厅康复产业研究院技术创新平台项目(No. 2015Y2001-38); 2.福建省科技厅引导性项目(No. 2017Y0043)

Effect of Baduanjin Combined with Biofeedback on Functional Defecation Disorders and Brain-gut Peptide

  • GAO Yuan ,
  • WANG Jing ,
  • CHEN Hui ,
  • WU Jia-yong ,
  • SHI Jing-yao ,
  • HUANG Ming-han
Expand
  • 1. Postgraduate College, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China;
    2. People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350004, China;
    3. The Second People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, China;
    4. Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, China

Received date: 2018-06-22

  Revised date: 2018-07-10

  Online published: 2018-09-27

摘要

目的 探讨八段锦联合生物反馈干预功能性排便障碍(FDD)的临床疗效及对血清脑肠肽的影响。方法 2017年6月至2018年2月,按随机数字表法将FDD患者68例分成对照组(n=34)和观察组(n=34)。两组均接受生物反馈疗法,观察组在生物反馈基础上接受八段锦功法锻炼,共12周。对两组临床总疗效,以及干预前后便秘主症积分、便秘患者生存质量问卷(PAC-QOL)和血清脑肠肽进行分析比较。结果 剔除脱落病例,观察组总疗效优于对照组(Z=-2.065, P=0.039)。干预后,两组便秘主症积分均改善(t>2.162, P<0.05),观察组干预后排便不尽感、排便时间、腹胀积分明显低于对照组(t>2.837, P<0.01),排便费力程度积分也低于对照组(t=-2.070, P<0.05);两组PAC-QOL积分均降低(t>2.085, P<0.05),观察组低于对照组(t=-2.243, P<0.05);两组血清5-羟色胺(5-HT)、一氧化氮(NO)、血管活性肽(VIP)均明显降低(t>2.420, P<0.05),血清P物质(SP)显著增高(t>6.780, P<0.001),观察组血清5-HT、NO、VIP均低于对照组(t>2.039, P<0.05),SP显著高于对照组(t=3.500, P<0.001)。结论 八段锦联合生物反馈可改善FDD患者临床疗效,其机制与调控脑肠肽的异常分泌和表达密切相关。

本文引用格式

高远 , 王菁 , 陈慧 , 吴加勇 , 施婧媱 , 黄铭涵 . 八段锦联合生物反馈对功能性排便障碍的疗效及脑肠肽的影响[J]. 中国康复理论与实践, 2018 , 24(9) : 1077 -1081 . DOI: 10.3969/j.issn.1006-9771.2018.09.018

Abstract

Objective To investigate the clinical efficacy of Baduanjin combined with biofeedback on functional defecation disorders and the effect on serum brain-gut peptide.Methods From June, 2017 to February, 2018, 68 patients were randomly divided into control group (n=34) and observation group (n=34). Both groups received biofeedback therapy, and the observation group took the training of Baduanjin in addition, for twelve weeks. Then, their overall clinical efficacy, main syndrome score of constipation, the score of Patient Assessment of Constipation Quality of Life (PAC-QOL) and Brain-gut peptide level were compared before and after intervention.Results The total clinical efficacy was higher in the observation group than in the control group (Z=-2.065, P=0.039) without shedding cases. After treatment, the main symptoms of constipation significantly improved (t>2.162, P<0.05) in both groups, while the defecation inactivity, defecation time and abdominal distension score were significantly lower in the observation group than in the control group (t>2.837, P<0.01), as well as the defecation strain (t=-2.070, P<0.05); the score of PAC-QOL decreased (t>2.085, P<0.05) in both groups, and was lower (t=-2.243, P<0.05) in the observation group than in the control group; the level of serum 5-hydroxytryptamine (5-HT), nitric oxide (NO) and vasoactive intestinal peptide (VIP) decreased (t>2.420, P<0.05), while the level of serum substance P (SP) increased (t>6.780, P<0.001), the level of serum 5-HT, serum NO and serum VIP was lower (t>2.039, P<0.05), and the level of serum SP was higher (t=3.500, P<0.001) in the observation group than in the control group.Conclusion Baduanjin combined with biofeedback can improve the clinical efficacy of patients with functional defecation disorders, and its mechanism is closely related to the regulation of abnormal secretion and the expression of brain-gut peptide.

参考文献

[1] 中华医学会消化病学分会胃肠动力学组. 中国慢性便秘诊治指南(2013,武汉)[J]. 胃肠病学, 2013, 18(10): 605-612.
[2] 王佩佩,罗雯,禹铮,等. 慢性便秘的研究进展[J]. 中国全科医学, 2017, 20(3): 370-373.
[3] 赵劢,谭至柔. 成年人慢性便秘流行病学的研究现状[J]. 世界华人消化杂志, 2014, 22(7): 939-944.
[4] 赵克,尹淑慧. 慢性便秘的诊断方法进展[J]. 中国中西医结合杂志, 2015, 35(4): 503-505.
[5] Lindberg G, Hamid SS, Malfertheiner P, et al.World Gastroenterology Organisation. World Gastroenterology Organisation global guideline: Constipation–a global perspective[J]. J Clin Gastroenterol, 2011, 45(6): 483-487.
[6] 罗云. 生物反馈治疗成人排便障碍型便秘的疗效荟萃分析[D]. 上海:上海交通大学, 2015.
[7] 王建月,丁勇,李云卿. 八段锦对中老年人生理机能影响的Meta分析[J]. 吉首大学学报(自然科学版), 2016, 37(2): 73-77, 82.
[8] 禹方,牛巧能. 健身气功八段锦在中医健康管理应用中的理论探讨[J]. 中国中医药现代远程教育, 2017, 15(22): 488-491.
[9] 赵亚云,焦娟,姜泉. 养生气功八段锦在疾病康复中应用进展[J]. 辽宁中医药大学学报, 2016, 15(12): 109-111.
[10] 郑筱萸. 中药新药临床研究指导原则(试行)[S]. 北京:中国医药科技出版社, 2002: 124-129.
[11] 中华中医药学会脾胃病分会. 便秘中医诊疗专家共识意见(2017)[J]. 中医杂志, 2017, 58(15): 1345-1350.
[12] Satish SCR, Adil EB, Giuseppe C, et al.Anorectal disorders[J]. Gastroenterology, 2016, 150(6): 1430-1442.
[13] Brian EL, Fermin M, Lin C, et al.Bowel disorders[J]. Gastroenterology, 2016, 150(6): 1393-1407.
[14] 古嫚,刘诗. 功能性便秘的研究进展[J]. 临床消化病杂志, 2014, 26(6): 324-325.
[15] 刘洋. 慢性便秘的病因与治疗研究进展[J]. 现代医药卫生, 2014, 30(10): 1496-1499.
[16] Mayer EA, Labus JS, Tillisch K, et al.Towards a systems view of IBS[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(10): 592-605.
[17] Pasricha PJ.Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about the future[J]. Gastroenterology, 2011, 140(4): 1126-1128.
[18] 宋玉磊,林征,柏亚妹. 功能性便秘疗效评估指标的现状与评价[J]. 中国实用内科杂志, 2016, 36(9): 813-816.
[19] 尹淑慧,赵克. 出口梗阻型便秘的诊治现状[J]. 临床外科杂志, 2018, 26(4): 262-264.
[20] 支晨阳,李为俊,周建华. 出口梗阻型便秘的治疗进展[J]. 中国老年学杂志, 2017, 37(16): 4166-4167.
[21] 赵亚云,焦娟,姜泉. 养生气功八段锦在疾病康复中应用进展[J]. 辽宁中医药大学学报, 2016, 18(12): 109-111.
[22] 连艳玲. 八段锦导引法对疾病治疗作用研究进展[J]. 中西医结合心血管病杂志, 2016, 5(31): 10-11, 13.
[23] 周洪伟,谢琪,刘保延,等. 八段锦对老年人身心健康影响的研究进展[J]. 世界科学技术:中医药现代化, 2016, 18(4): 671-676.
[24] 冯毅挪,卞伯高,潘华山,等. 八段锦运动对老年便秘型肠易激综合征的疗效观察[J]. 体育科研, 2010, 31(2): 89-90, 98.
[25] 孙红梅. 健身气功八段锦练习对老年人肠道菌群的影响[J]. 中国运动医学杂志, 2012, 31(11): 973-977.
文章导航

/